Ethic Inc’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-10,730
Closed -$278K 1015
2023
Q1
$278K Sell
10,730
-485
-4% -$13K 0.01% 803
2022
Q4
$265K Buy
+11,215
New +$302K 0.01% 756
2022
Q3
Sell
-8,034
Closed -$267K 838
2022
Q2
$267K Buy
8,034
+2,992
+59% +$127K 0.02% 649
2022
Q1
$364K Buy
5,042
+1,064
+27% +$76.7K 0.03% 548
2021
Q4
$365K Buy
3,978
+704
+22% +$84.1K 0.03% 479
2021
Q3
$415K Buy
3,274
+782
+31% +$114K 0.04% 406
2021
Q2
$414K Buy
2,492
+939
+60% +$152K 0.05% 386
2021
Q1
$282K Buy
+1,553
New +$360K 0.05% 401

Other funds holding TDOC

Ethic Inc's TDOC Position: Q2 2023 in Review

Ethic Inc sold out of Teladoc Health (TDOC) in Q2 2023, closing a stake of 10,730 shares — an estimated $278K sold.

Ethic Inc first reported a position in TDOC in Q1 2021 and held it in 8 quarters. The position peaked at $415K in Q3 2021. 431 funds tracked by Wall St. Rank hold TDOC as of Q2 2023.

  • Ethic Inc reported no remaining Teladoc Health position as of Q2 2023 after selling out during the quarter.
  • Ethic Inc sold 10,730 Teladoc Health shares in Q2 2023, an estimated $278K.
  • Ethic Inc first reported a position in Teladoc Health in Q1 2021 and held it in 8 quarters.
  • Ethic Inc's Teladoc Health position peaked at $415K in Q3 2021.
  • 431 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2023.

Based on Ethic Inc's 13F filing for Q2 2023, filed 14 Aug 2023.